Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation
暂无分享，去创建一个
B. Pégourié | S. Iacobelli | G. Gahrton | A. Gratwohl | D. Niederwieser | M. Vekemans | R. Hájek | P. Moreau | H. Ludwig | N. Gorin | J. Harousseau | T. Masszi | B. Hertenstein | C. Doyen | T. Witte | G. Milone | Curly T C M Morris | L. Garderet | C. Chaleteix | D. Caillot | M. Michallet | F. Onida | P. Casassus | N. Ketterer | M. Dib | J. Fontan | B. Kolb | A. Daguenel